The grants to four scientists at Columbia University Vagelos College of Physicians and Surgeons support unconventional approaches to major challenges in biomedical and behavioral research.
Physician-scientist Juanma Schvartzman is a firm believer that his curiosity-driven research on cell metabolism and its influence on cell identity will offer clues for better cancer treatments.
A new study finds that many of our genes, if disabled by a mutation, have a surprising ability to turn on backup genes to compensate for lost functions.
Columbia's Maja Bergman discuss the types of challenges domestic violence survivors face, effective therapies for those who experience domestic abuse, and warning signs that someone may be an abuser.
An international study shows as many as one-quarter of unresponsive patients with brain injuries have some level of awareness, a finding that could spur development of new treatments.
PARP inhibitors have improved survival of breast cancer patients with BRCA1/2 mutations, but the cancer eventually returns. A Columbia study has now identified a drug that may prevent that relapse.
Columbia researchers found that exposure to famine early in gestation—but not in the first years of life or late gestation—increased the risk of developing type 2 diabetes decades later.
A model that examines the dynamics underlying suicide contagion following a celebrity death could help in developing a rapid response to prevent suicide.
The study by Columbia researchers adds to emerging evidence that environmental metals are preventable risk factors of cardiovascular disease and mortality.
Four Columbia researchers were awarded pilot grants—made possible by proceeds from Velocity, Columbia’s annual cycling fundraiser—to support their early-stage cancer research.
A “loopy” discovery in bacteria is raising fundamental questions about the makeup of our own genome. And revealing a potential wellspring of material for new genetic therapies.
Four faculty at Vagelos College of Physicians and Surgeons have been named Irving Scholars and will receive funding to support their clinical research over the next four years.